ES2531459B1 - Método para la separación física de "traductomas" convolucionados - Google Patents

Método para la separación física de "traductomas" convolucionados Download PDF

Info

Publication number
ES2531459B1
ES2531459B1 ES201300566A ES201300566A ES2531459B1 ES 2531459 B1 ES2531459 B1 ES 2531459B1 ES 201300566 A ES201300566 A ES 201300566A ES 201300566 A ES201300566 A ES 201300566A ES 2531459 B1 ES2531459 B1 ES 2531459B1
Authority
ES
Spain
Prior art keywords
traductomas
rebivas
partners
translactomas
convoluted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES201300566A
Other languages
English (en)
Other versions
ES2531459A1 (es
Inventor
Antonio VILA SANJURJO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES201300566A priority Critical patent/ES2531459B1/es
Publication of ES2531459A1 publication Critical patent/ES2531459A1/es
Application granted granted Critical
Publication of ES2531459B1 publication Critical patent/ES2531459B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Método para la separación física de “traductomas” convolucionados.#Este método se basa en una rápida lisis para todos los socios presentes en ReBiVaS (relaciones biológicas de varios socios) y ReBiVaS-AD, (relaciones biológicas de varios socios altamente desequilibradas) seguida de un procedimiento de aislamiento que permita la separación de los “traductomas” individuales de cada uno de los socios. Los diferentes “traductomas” involucrados en ReBiVaS y ReBiVaS-AD son capturados por medio de un número igual de tipos de anticuerpos con especificidad hacia una proteína-r específica de cada uno de dichos “traductomas”. Tras su captura en resinas de cromatografía independientes y colocadas en tandem, dichos “traductomas” son eluídos por separado.#Se propone el desarrollo de anticuerpos específicos para zonas no conservadas de proteínas ribosómicas (proteínas-r) de modo que diferentes “traductomas” presentes en una misma muestra puedan ser fácilmente separados.

Description

imagen1
imagen2
imagen3
DESCRIPCIÓN
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
imagen24
imagen25
imagen26
imagen27
imagen28
imagen29
imagen30
imagen31
imagen32
imagen33
imagen34
imagen35
imagen36

Claims (1)

  1. imagen1
    imagen2
    imagen3
    REIVINDICACIONES
    imagen4
    imagen5
    imagen6
    imagen7
    imagen8
ES201300566A 2013-06-10 2013-06-10 Método para la separación física de "traductomas" convolucionados Expired - Fee Related ES2531459B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201300566A ES2531459B1 (es) 2013-06-10 2013-06-10 Método para la separación física de "traductomas" convolucionados

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201300566A ES2531459B1 (es) 2013-06-10 2013-06-10 Método para la separación física de "traductomas" convolucionados

Publications (2)

Publication Number Publication Date
ES2531459A1 ES2531459A1 (es) 2015-03-16
ES2531459B1 true ES2531459B1 (es) 2015-12-28

Family

ID=52630547

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201300566A Expired - Fee Related ES2531459B1 (es) 2013-06-10 2013-06-10 Método para la separación física de "traductomas" convolucionados

Country Status (1)

Country Link
ES (1) ES2531459B1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
EP0764658B1 (de) * 1995-09-22 2002-01-02 ZLB Bioplasma AG Verfahren zur Gewinnung von Immunglobulinen aus Fraktionen, die bei der Fraktionierung von menschlichem Blutplasma entstehen
EP2500073A1 (en) * 2011-03-17 2012-09-19 ChromaCon AG Method for identification and purification of multi-specific polypeptides

Also Published As

Publication number Publication date
ES2531459A1 (es) 2015-03-16

Similar Documents

Publication Publication Date Title
BR112018016226A8 (pt) Anticorpo antilipoarabinomanana (anti-lam) monoclonal humano, kit para detectar pelo menos um epítopo de lam, método para diagnosticar uma infecção de tuberculose ativa em um indivíduo, método para tratar uma infecção de tuberculose em um indivíduo, anticorpo monoclonal humano anti-lam e método de pré-concentração de lam a partir de uma amostra biológica
WO2015138497A3 (en) Systems and methods for rapid data analysis
ES2672139A1 (es) Dispositivo recolector de muestras de orina para pacientes dependientes
AR053948A1 (es) Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondiente
BR112018068469A2 (pt) método e sistema de detecção de defeitos eletromagnéticos.
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
EP2853895A3 (en) Methods, apparatus and systems for detection of total protein using capillary electrophoresis
EP3546937A4 (en) METHOD, SYSTEM, REAGENT KIT AND SYSTEM FOR CHECKING A HIGH DOSE HOOK SAMPLE AND FOR IMMUNOASSAY
JP2014232117A5 (es)
MX2015013596A (es) Metodos, dispositivos y sistemas para analisis de muestras.
ES2684758T3 (es) Procedimiento para diagnosticar fibrosis hepática
ES2531459B1 (es) Método para la separación física de "traductomas" convolucionados
EP3812759A4 (en) METHOD FOR SEPARATION OF ANTIBODIES, AND METHOD FOR TESTING FOR A DISEASE
AR108771A1 (es) MÉTODO PARA LA DETECCIÓN DE UN ANTICUERPO IgM ESPECÍFICO PARA UN FLAVIVIRUS EN UNA MUESTRA
BR112018017336A2 (pt) método in vitro para detectar um anticorpo para p53 (anticorpo anti-p53) em uma amostra e polipeptídeo de fusão
JP2018528441A5 (es)
EP3306319A4 (en) TEST OBJECT DETECTION METHOD, AND IMMUNOLOGICAL ASSAY INSTRUMENT AND MONOCLONAL ANTIBODY THEREOF
ES2527887B1 (es) Procedimiento para cuantificar la presencia de un antígeno de Helicobacter pylori en una muestra biológica de origen fecal y kit para cuantificar la presencia de dicho antígeno mediante dicho método
MX2016017048A (es) Inmunoensayo reactivo y colaborativo potenciado por enzimas (ceer) usando citometria de flujo.
EP3753922A4 (en) COMPOSITION FOR DETECTION OF BICATENARY RNA, CONSISTING OF A MEROCYANINE COMPOUND AND AN ISOMER OF THE SAME, AND METHOD OF PROVIDING INFORMATION FOR DIAGNOSING CANCER, USING BICATENARY RNA EXPRESSION ANALYSIS
EP3760641A4 (en) MONOCLONAL ANTIBODIES AGAINST APOA4, IMMUNOASSAY AND KIT FOR MEASUREMENT
WO2016111538A3 (ko) 성호르몬 검출용 시약 키트 및 이를 이용한 성호르몬 검출 방법
MX2019002269A (es) Anticuerpo monoclonal contra quinasa de cremallera de leucina embrionaria materna (melk) y utilizacion del mismo.
ES2441291B1 (es) Método y dispositivo para el diagnóstico rápido de enfermedades causadas por Yersinia, en muestras fecales
WO2016123165A3 (en) Methods for immuno chromatographic assay desensitization

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2531459

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20151228

FD2A Announcement of lapse in spain

Effective date: 20210915